Article info
PDFOriginal research
Rapid clinical mutational testing of KRAS, BRAF and EGFR: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing
- Correspondence to Dr Matthias Van Haele, KU Leuven, Leuven 3000, Belgium; matthias.vanhaele{at}uzleuven.be
Citation
Rapid clinical mutational testing of KRAS, BRAF and EGFR: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing
Publication history
- Received May 13, 2019
- Revised June 24, 2019
- Accepted June 25, 2019
- First published July 11, 2019.
Online issue publication
September 21, 2020
Article Versions
- Previous version (12 December 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.